drugset / Trial / NCT01148277

Propofol and Remifentanyl Versus Midazolam and Fentanyl for Diagnostic Colonoscopy in Patients With Compensated Cirrhosis Child A-B

NCT01148277 ↗

Unknown 90 enrolled Ziv Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective, randomized-controlled trial (RCT) comparing the use of Propofol and Remifentanyl and traditional sedation (Midazolam and Fentanyl) for diagnostic colonoscopies in patients with compensated cirrhosis child A-B. The working hypothesis is that the use of propofol will be translated in a shorter recovery and discharge times with a higher patient satisfaction and a decrease in general complications (Hepatic Encephalopathy) in the context of patients with advanced liver disease.

Timeline

Start
2011-08
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified — —
Comparator Midazolam Small molecule — —
Comparator Propofol Small molecule — —
Comparator Remifentnyl Unknown — —

Indications